AMP2SEQ service miseq, per library mtai-m; mtbi-m (6 samples

Ended Purchase Order Awarded Last action

Contract number
HHSN261201800245P
Awardee
Awarding agency
Obligated
$4,350

Award facts

Contract value 100% obligated
$4,350.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$70
Original award $4,420

About this award

The National Cancer Institute awarded a purchase order to Irepertoire Inc. for $4,350.00 on March 16, 2018, for AMP2SEQ service MiSeq per library MTAI-M and MTBI-M processing of six samples. Performance occurs in Bethesda, Maryland, with an ultimate completion date of April 30, 2018. Irepertoire Inc. is a small disadvantaged business specializing in molecular biology and immunological research services, including T-cell receptor sequencing and deep immune repertoire analysis.

Quick answers

Who was awarded contract HHSN261201800245P?

HHSN261201800245P was awarded to Irepertoire Inc. by National Cancer Institute (National Institutes of Health) on March 16, 2018.

How much is contract HHSN261201800245P worth?

The government has obligated $4,350 on HHSN261201800245P.

Was contract HHSN261201800245P competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award